Neurological Disorders Clinical Trials

Full title:

A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study Assessing Safety, Tolerability, Pharmacodynamics, Efficacy and Pharmacokinetics of DYNE-251 Administered to Participants with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping

Study goal:

The main goal of this study is to see if DYNE-251 is safe to use in young males with DMD. Researchers also want to find out how well DYNE-251 treats the disease and how it affects the body in other ways.

Diagnosis:

Duchenne muscular dystrophy

Age:

Male, age 4 to 16 years old

Study goal:

To learn more about participants beliefs, attitudes, and questions about gene therapy to help make web-based resources to share information. This could help patients make treatment decisions.

Diagnosis:

Neurological disorders, sickle cell disease, hemophilia, inherited genetic diseases

Age:

18 to 35 years old with rare genetic diseases

Full title:

 Inherited Neuropathies Consortium Rare Disease Clinical Research Network

Study goal:

This long-term study aims to better understand the genetic causes of Charcot-Marie-Tooth disease (CMT) and to learn how different forms of the rare hereditary disease affect people over time.

Diagnosis:

Charcot-Marie-Tooth Disease

Age:

Birth to 22 years

Full title:

TBANK: Protocol for Collecting, Banking, and Distributing Human Tissue Samples: St. Jude Children’s Research Hospital Biorepository

Study goal:

To provide a high-quality repository of tumor and normal samples to facilitate translational research performed by St Jude faculty and their collaborators

Diagnosis:

All diseases

Full title:

Friedreich’s Ataxia Global Clinical Consortium UNIFIED Natural History Study (UNIFAI)

Study goal:

To collect data about how Friedreich’s ataxia progresses over time and affects the daily life of patients.

Diagnosis:

Friedreich’s ataxia

Age:

Any